Rekah Pharmaceutical Industry Ltd (REKA) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.099x

Based on the latest financial reports, Rekah Pharmaceutical Industry Ltd (REKA) has a cash flow conversion efficiency ratio of 0.099x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA13.82 Million ≈ $37.04K USD) by net assets (ILA140.18 Million ≈ $375.83K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Rekah Pharmaceutical Industry Ltd (REKA) total market value for the company's overall valuation and market capitalisation.

Rekah Pharmaceutical Industry Ltd - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Rekah Pharmaceutical Industry Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Rekah Pharmaceutical Industry Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Rekah Pharmaceutical Industry Ltd ranked by their cash flow conversion efficiency. Explore REKA cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Central Petroleum Ltd AU:CTP	0.120x
Kafein Yazilim IS:KFEIN	0.024x
Generations Bancorp NY Inc NASDAQ:GBNY	0.047x
Jack Chia Industries (Thailand) Public Company Limited BK:JCT	0.022x
Kunming Longjin Pharmaceutical Co Ltd SHE:002750	-0.014x
Lotte Chilsung Beverage Co Ltd KO:005305	0.042x
Lii Hen Industries Bhd KLSE:7089	0.033x
Satria Mega Kencana Tbk PT JK:SOTS	-0.009x

Annual Cash Flow Conversion Efficiency for Rekah Pharmaceutical Industry Ltd (2004–2025)

The table below shows the annual cash flow conversion efficiency of Rekah Pharmaceutical Industry Ltd from 2004 to 2025. View latest Rekah Pharmaceutical Industry Ltd stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	ILA144.21 Million ≈ $386.62K	ILA12.95 Million ≈ $34.72K	0.090x	-45.20%
2024-12-31	ILA161.98 Million ≈ $434.25K	ILA26.54 Million ≈ $71.16K	0.164x	-10.07%
2023-12-31	ILA155.59 Million ≈ $417.12K	ILA28.35 Million ≈ $76.01K	0.182x	-24.28%
2022-12-31	ILA162.08 Million ≈ $434.53K	ILA39.00 Million ≈ $104.56K	0.241x	+96.73%
2021-12-31	ILA173.06 Million ≈ $463.98K	ILA21.17 Million ≈ $56.75K	0.122x	+79.52%
2020-12-31	ILA165.59 Million ≈ $443.94K	ILA11.28 Million ≈ $30.25K	0.068x	-68.81%
2019-12-31	ILA155.22 Million ≈ $416.13K	ILA33.91 Million ≈ $90.92K	0.218x	+90.45%
2018-12-31	ILA150.66 Million ≈ $403.91K	ILA17.28 Million ≈ $46.34K	0.115x	-30.28%
2017-12-31	ILA144.62 Million ≈ $387.73K	ILA23.80 Million ≈ $63.80K	0.165x	-23.69%
2016-12-31	ILA105.86 Million ≈ $283.81K	ILA22.82 Million ≈ $61.19K	0.216x	+359.22%
2015-12-31	ILA123.66 Million ≈ $331.52K	ILA5.81 Million ≈ $15.57K	0.047x	+172.04%
2014-12-31	ILA77.06 Million ≈ $206.59K	ILA1.33 Million ≈ $3.57K	0.017x	-88.28%
2013-12-31	ILA79.51 Million ≈ $213.17K	ILA11.71 Million ≈ $31.38K	0.147x	-26.12%
2012-12-31	ILA71.17 Million ≈ $190.79K	ILA14.18 Million ≈ $38.02K	0.199x	+88.75%
2010-12-31	ILA63.78 Million ≈ $171.00K	ILA6.73 Million ≈ $18.05K	0.106x	-73.98%
2009-12-31	ILA64.15 Million ≈ $171.99K	ILA26.03 Million ≈ $69.78K	0.406x	+261.86%
2008-12-31	ILA58.62 Million ≈ $157.17K	ILA6.57 Million ≈ $17.62K	0.112x	-39.57%
2007-12-31	ILA67.10 Million ≈ $179.88K	ILA12.45 Million ≈ $33.38K	0.186x	+155.46%
2005-12-31	ILA58.85 Million ≈ $157.77K	ILA4.27 Million ≈ $11.46K	0.073x	-80.15%
2004-12-31	ILA48.86 Million ≈ $131.00K	ILA17.87 Million ≈ $47.92K	0.366x	--

About Rekah Pharmaceutical Industry Ltd

TA:REKA Israel Drug Manufacturers - Specialty & Generic

Market Cap

$34.58 Million

ILA12.90 Billion ILA

Market Cap Rank

#23372 Global

#322 in Israel

Share Price

ILA1130.00

Change (1 day)

+0.00%

52-Week Range

ILA1007.00 - ILA1300.00

All Time High

ILA3846.55